Maria Isabel Loza PhD

Professor of Pharmacology and head of BioFarma pharmacology research group at the University of Santiago de Compostela. Leader in the field of Early Drug Discovery at Spanish and European levels, endorsed by the participation in more than 89 research programs as principal investigator, founded by public and private institutions. Active participation in the development of 15 NCE that have reached clinical trials in the specific programmes of R&D transfer in drug development of different pharmaceutical companies.

Author of 208 articles in indexed journals in the Journal Citation Report and more than 300 contributions at national and international congresses in Pharmacology, Medicinal Chemistry and Drug Discovery. Has supervised 25 PhD theses and more than 100 postgraduate research projects, all awarded the highest marks. Reviewer of several journals in the areas of pharmacology, medicinal chemistry and drug discovery.

Coordinator of the Drug Discovery Galician Network (2007-onwards). the Drug Discovery Spanish Network of Excellence (REDEFAR) and the ES-OPENSCREEN Network connected to the ERIC EU- OPENSCREEN (European Research Infraestructure Consortium).

Board of trustees of Kæertor Foundation, non for profit foundation for promoting reciprocal transference in open innovation in drug discovery.

As entrepreneur, she has promoted the foundation of three companies (Pharmatools Digital Interactive SL, Allelyus, Oncostellae and Celtarys).